Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 1/2019

12.03.2019 | Vasovagal Syncope

The benefit of closed loop stimulation in patients with cardioinhibitory vasovagal syncope confirmed by head-up tilt table testing: a systematic review and meta-analysis

verfasst von: Mohammed Ruzieh, Mehrdad Ghahramani, Matthew Nudy, Gerald V. Naccarelli, John Mandrola, Blair P. Grubb, Andrew J. Foy

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

A proportion of patients with vasovagal syncope (VVS) experience recurrence despite appropriate management. Closed loop stimulation (CLS) pacing is a promising treatment for a subgroup of patients with cardioinhibitory response on head-up tilt table test (HUTT). Nonetheless, its efficacy remains uncertain. We sought to assess the efficacy of CLS pacing in patients with cardioinhibitory VVS.

Methods

We searched PubMed, Google Scholar, and the Cochrane Central Register of controlled trials for relevant studies (last search date April 23, 2018). Data were pooled using the Mantel-Haenszel fixed-effects model. For cohort studies, we used a Freeman-Tukey transformation to calculate the weighted summary proportion. Primary outcomes are syncope and presyncope.

Results

Eight studies were included in the final analyses (two single-blinded and one double-blinded RCT, two prospective observational studies, and three retrospective observational studies). Two hundred ninety-one patients included, with an average age of 57 years. Quality of evidence is moderate. Use of CLS pacing was associated with reduced risk of syncope (OR 0.08; 95% CI 0.03–0.18; I2 32%) and presyncope (OR 0.34; 95% CI 0.18–0.63; I2 0.00%). Using proportion meta-analysis, the summary estimate of the proportion of cases that developed syncope during CLS pacing was similar between RCTs and prospective studies (3.2% and 3.1%), respectively. This is much lower than the rate of recurrence in the control arm of RCTs at 33.7%. Sensitivity analyses yielded similar results.

Conclusion

CLS pacing is beneficial for patients with recurrent vasovagal syncope who demonstrate a cardioinhibitory response on HUTT.
Literatur
1.
Zurück zum Zitat Soteriades ES, Evans JC, Larson MG, Chen MH, Chen L, Benjamin EJ, et al. Incidence and prognosis of Syncope. N Engl J Med. 2002;347:878–85.CrossRefPubMed Soteriades ES, Evans JC, Larson MG, Chen MH, Chen L, Benjamin EJ, et al. Incidence and prognosis of Syncope. N Engl J Med. 2002;347:878–85.CrossRefPubMed
2.
Zurück zum Zitat Mosqueda-Garcia R, Furlan R, Tank J, Fernandez-Violante R. The elusive pathophysiology of neurally mediated syncope. Circulation. 2000;102:2898–906.CrossRefPubMed Mosqueda-Garcia R, Furlan R, Tank J, Fernandez-Violante R. The elusive pathophysiology of neurally mediated syncope. Circulation. 2000;102:2898–906.CrossRefPubMed
3.
Zurück zum Zitat Connolly SJ, Sheldon R, Thorpe KE, Roberts RS, Ellenbogen KA, Wilkoff BL, et al. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: second vasovagal pacemaker study (VPS II): a randomized trial. JAMA. 2003;289:2224–9.CrossRefPubMed Connolly SJ, Sheldon R, Thorpe KE, Roberts RS, Ellenbogen KA, Wilkoff BL, et al. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: second vasovagal pacemaker study (VPS II): a randomized trial. JAMA. 2003;289:2224–9.CrossRefPubMed
4.
Zurück zum Zitat Brignole M, Menozzi C, Moya A, Andresen D, Blanc JJ, Krahn AD, et al. Pacemaker therapy in patients with neurally mediated syncope and documented asystole. Circulation. 2012;125:2566–71.CrossRefPubMed Brignole M, Menozzi C, Moya A, Andresen D, Blanc JJ, Krahn AD, et al. Pacemaker therapy in patients with neurally mediated syncope and documented asystole. Circulation. 2012;125:2566–71.CrossRefPubMed
5.
Zurück zum Zitat Shen W-K, Sheldon RS, Benditt DG, Cohen MI, Forman DE, Goldberger ZD, et al. 2017 ACC/AHA/HRS guideline for the evaluation and Management of Patients with Syncope: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines, and the Heart Rhythm Society. Circulation. 2017;136:e60–e122.PubMed Shen W-K, Sheldon RS, Benditt DG, Cohen MI, Forman DE, Goldberger ZD, et al. 2017 ACC/AHA/HRS guideline for the evaluation and Management of Patients with Syncope: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines, and the Heart Rhythm Society. Circulation. 2017;136:e60–e122.PubMed
6.
Zurück zum Zitat Brignole M, Moya A, de Lange FJ, Deharo J-C, Elliott PM, Fanciulli A, et al. 2018 ESC guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39:1883–948.CrossRefPubMed Brignole M, Moya A, de Lange FJ, Deharo J-C, Elliott PM, Fanciulli A, et al. 2018 ESC guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39:1883–948.CrossRefPubMed
7.
Zurück zum Zitat Ruzieh M, Ammari Z, Dasa O, Karim S, Grubb B. Role of closed loop stimulation pacing (CLS) in vasovagal syncope. Pacing Clin Electrophysiol. 2017;40:1302–7.CrossRefPubMed Ruzieh M, Ammari Z, Dasa O, Karim S, Grubb B. Role of closed loop stimulation pacing (CLS) in vasovagal syncope. Pacing Clin Electrophysiol. 2017;40:1302–7.CrossRefPubMed
8.
Zurück zum Zitat Baron-Esquivias G, Morillo CA, Moya-Mitjans A, Martinez-Alday J, Ruiz-Granell R, Lacunza-Ruiz J, et al. Dual-chamber pacing with closed loop stimulation in recurrent reflex vasovagal syncope:the SPAIN study. J Am Coll Cardiol. 2017;70:1720–8.CrossRefPubMed Baron-Esquivias G, Morillo CA, Moya-Mitjans A, Martinez-Alday J, Ruiz-Granell R, Lacunza-Ruiz J, et al. Dual-chamber pacing with closed loop stimulation in recurrent reflex vasovagal syncope:the SPAIN study. J Am Coll Cardiol. 2017;70:1720–8.CrossRefPubMed
9.
Zurück zum Zitat Freeman MF, Tukey JW. Transformations related to the angular and the square root. Ann Math Stat. 1950;21:607–11.CrossRef Freeman MF, Tukey JW. Transformations related to the angular and the square root. Ann Math Stat. 1950;21:607–11.CrossRef
10.
Zurück zum Zitat Occhetta E, Bortnik M, Audoglio R, Vassanelli C. Closed loop stimulation in prevention of vasovagal syncope. Inotropy controlled pacing in vasovagal syncope (INVASY): a multicentre randomized, single blind, controlled study. Europace. 2004;6:538–47.CrossRefPubMed Occhetta E, Bortnik M, Audoglio R, Vassanelli C. Closed loop stimulation in prevention of vasovagal syncope. Inotropy controlled pacing in vasovagal syncope (INVASY): a multicentre randomized, single blind, controlled study. Europace. 2004;6:538–47.CrossRefPubMed
11.
Zurück zum Zitat Russo V, Rago A, Papa AA, Golino P, Calabrò R, Russo MG, et al. The effect of dual-chamber closed-loop stimulation on syncope recurrence in healthy patients with tilt-induced vasovagal cardioinhibitory syncope: a prospective, randomised, single-blind, crossover study. Heart. 2013;99:1609–13.CrossRefPubMed Russo V, Rago A, Papa AA, Golino P, Calabrò R, Russo MG, et al. The effect of dual-chamber closed-loop stimulation on syncope recurrence in healthy patients with tilt-induced vasovagal cardioinhibitory syncope: a prospective, randomised, single-blind, crossover study. Heart. 2013;99:1609–13.CrossRefPubMed
12.
Zurück zum Zitat Griesbach L, Huber T, Knote B, HÄRTEL J. Closed loop stimulation: therapy for malignant neurocardiogenic syncope. Prog Biomed Res. 2002;7:242–7. Griesbach L, Huber T, Knote B, HÄRTEL J. Closed loop stimulation: therapy for malignant neurocardiogenic syncope. Prog Biomed Res. 2002;7:242–7.
13.
Zurück zum Zitat Occhetta E, Bortnik M, Vassanelli C. The DDDR closed loop stimulation for the prevention of vasovagal syncope: results from the INVASY prospective feasibility registry. Europace. 2003;5:153–62.CrossRefPubMed Occhetta E, Bortnik M, Vassanelli C. The DDDR closed loop stimulation for the prevention of vasovagal syncope: results from the INVASY prospective feasibility registry. Europace. 2003;5:153–62.CrossRefPubMed
14.
Zurück zum Zitat Palmisano P, Zaccaria M, Luzzi G, Nacci F, Anaclerio M, Favale S. Closed-loop cardiac pacing vs conventional dual-chamber pacing with specialized sensing and pacing algorithms for syncope prevention in patients with refractory vasovagal syncope: results of a long-term follow-up. Europace. 2012;14:1038–43.CrossRefPubMed Palmisano P, Zaccaria M, Luzzi G, Nacci F, Anaclerio M, Favale S. Closed-loop cardiac pacing vs conventional dual-chamber pacing with specialized sensing and pacing algorithms for syncope prevention in patients with refractory vasovagal syncope: results of a long-term follow-up. Europace. 2012;14:1038–43.CrossRefPubMed
15.
Zurück zum Zitat Bortnik M, Occhetta E, Dell'Era G, Secco GG, Degiovanni A, Plebani L, et al. Long-term follow-up of DDDR closed-loop cardiac pacing for the prevention of recurrent vasovagal syncope. J Cardiovasc Med (Hagerstown). 2012;13:242–5.CrossRef Bortnik M, Occhetta E, Dell'Era G, Secco GG, Degiovanni A, Plebani L, et al. Long-term follow-up of DDDR closed-loop cardiac pacing for the prevention of recurrent vasovagal syncope. J Cardiovasc Med (Hagerstown). 2012;13:242–5.CrossRef
16.
Zurück zum Zitat Anguera Ramos I, Rodrigeus F, Di Marco A, Dallaglio P, Sebate X, Cequier A. Effectiveness of closed loop stimulation pacing in preventing disabling cardioinhibitory vasovagal syncope. A single-center experience. Eur Heart J. 2015;36(223):SUPPL. 1. Anguera Ramos I, Rodrigeus F, Di Marco A, Dallaglio P, Sebate X, Cequier A. Effectiveness of closed loop stimulation pacing in preventing disabling cardioinhibitory vasovagal syncope. A single-center experience. Eur Heart J. 2015;36(223):SUPPL. 1.
17.
Zurück zum Zitat Rattanawong P, Riangwiwat T, Chongsathidkiet P, Vutthikraivit W, Limpruttidham N, Prasitlumkum N, et al. Closed-looped stimulation cardiac pacing for recurrent vasovagal syncope: a systematic review and meta-analysis. J Arrhythm. 2018;34:556–64.CrossRefPubMedPubMedCentral Rattanawong P, Riangwiwat T, Chongsathidkiet P, Vutthikraivit W, Limpruttidham N, Prasitlumkum N, et al. Closed-looped stimulation cardiac pacing for recurrent vasovagal syncope: a systematic review and meta-analysis. J Arrhythm. 2018;34:556–64.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Raviele A, for the Vasovagal S, Pacing Trial I, Giada F, et al. A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE). Eur Heart J. 2004;25:1741–8.CrossRefPubMed Raviele A, for the Vasovagal S, Pacing Trial I, Giada F, et al. A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE). Eur Heart J. 2004;25:1741–8.CrossRefPubMed
19.
Zurück zum Zitat Yu S, Kanjwal K, He W, Ren K, Cooper E, Karabin B, et al. A long-term follow-up on the use of closed-loop cardiac pacing in patients with refractory neurocardiogenic syncope. The Journal of Innovations in Cardiac Rhythm management. 2015;6:1982–5. Yu S, Kanjwal K, He W, Ren K, Cooper E, Karabin B, et al. A long-term follow-up on the use of closed-loop cardiac pacing in patients with refractory neurocardiogenic syncope. The Journal of Innovations in Cardiac Rhythm management. 2015;6:1982–5.
20.
Zurück zum Zitat Brignole M, Donateo P, Tomaino M, Massa R, Iori M, Beiras X, et al. Benefit of pacemaker therapy in patients with presumed neurally mediated syncope and documented asystole is greater when tilt test is negative. Circ Arrhythm Electrophysiol. 2014;7:10–6.CrossRefPubMed Brignole M, Donateo P, Tomaino M, Massa R, Iori M, Beiras X, et al. Benefit of pacemaker therapy in patients with presumed neurally mediated syncope and documented asystole is greater when tilt test is negative. Circ Arrhythm Electrophysiol. 2014;7:10–6.CrossRefPubMed
21.
Zurück zum Zitat Sud S, Massel D, Klein GJ, Leong-Sit P, Yee R, Skanes AC, et al. The expectation effect and cardiac pacing for refractory vasovagal syncope. Am J Med. 2007;120:54–62.CrossRefPubMed Sud S, Massel D, Klein GJ, Leong-Sit P, Yee R, Skanes AC, et al. The expectation effect and cardiac pacing for refractory vasovagal syncope. Am J Med. 2007;120:54–62.CrossRefPubMed
Metadaten
Titel
The benefit of closed loop stimulation in patients with cardioinhibitory vasovagal syncope confirmed by head-up tilt table testing: a systematic review and meta-analysis
verfasst von
Mohammed Ruzieh
Mehrdad Ghahramani
Matthew Nudy
Gerald V. Naccarelli
John Mandrola
Blair P. Grubb
Andrew J. Foy
Publikationsdatum
12.03.2019
Verlag
Springer US
Schlagwort
Vasovagal Syncope
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 1/2019
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-019-00531-0

Weitere Artikel der Ausgabe 1/2019

Journal of Interventional Cardiac Electrophysiology 1/2019 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.